• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Bowdoin Science Journal

  • Home
  • About
    • Our Mission
    • Our Staff
  • Sections
    • Biology
    • Chemistry and Biochemistry
    • Math and Physics
    • Computer Science and Technology
    • Environmental Science and EOS
    • Honors Projects
    • Psychology and Neuroscience
  • Contact Us
  • Fun Links
  • Subscribe

Natalie Hayden

Chernobyl Wolves Living with Cancer

April 21, 2024 by Natalie Hayden

A peculiar phenomenon is occurring in Chernobyl, Ukraine. It has been a ghost town since the nuclear accident in 1986, and radiation levels are too high for humans to live safely. When the accident occurred, it released over 100,000 lbs of radioactive material into the atmosphere which was dispersed across Europe and the USSR. Over 100,000 people were evacuated from over 200 villages. An exclusion zone with a 30 km radius was created to protect humans from the radiation that still remains (NPR, 2024). The level of radiation varies within the CEZ because wind and rain spread the radiation when the accident occurred. Wolves are in a unique position as the apex predators– they encounter radiation exposure at every level of the food chain. From a contaminated deer eating contaminated grass, wolves are one of the most radiation-exposed animals in the CEZ. The wolves in the CEZ are exposed to much higher levels of radiation than are considered safe for humans. For humans, the annual limit is 1 mGy, but for wolves, they are exposed to 2.6-35.7 mGy on a daily basis (MIT News, 1994). Despite this high level of radiation, the wildlife is thriving, filled with elk, deer, boar, and wolves. While radiation is typically thought of as a risk for developing cancer, the Chernobyl grey wolf population is thriving in tandem with this disease, developing a population that is nearly seven times as dense as surrounding wolf populations. Puzzled by their strange ability to survive in these harsh conditions, researchers set out to determine what was going on. Scientists measured nine wolves’ movement and radiation levels within the CEZ through a GPS containment-monitor for six months. They found that the level of radiation varied depending on where the wolves were within the CEZ (Hinton et al., 2019). Although the level of contamination varies, these high levels of radiation may be enough to drive natural selection, helping wolves thrive in these harsh conditions (Love et. al, 2020). 

Scientists set out to uncover if the radiation from Chernobyl was enough to drive natural selection, allowing the population to evolve in such a way to protect it from radiation. Researchers analyzed the wolves’ fecal samples for parasites, took blood samples to sequence the full blood transcriptomes, a collection of mRNA transcripts, and muscle tissue samples. The study also looked at the blood cell composition of these wolves, to take a closer look at the immune cells, which are indicative of different types of stress or disease (Love et. al, 2020). The study compared CEZ wolves to those in Belarus, outside of the CEZ, and to wolves in Yellowstone National Park (NPR, 2024). They found that some of the fastest-evolving genes “have some role in cancer immune response or the anti-tumor response in mammals” (NPR, 2024). These genes are called Endogenous Retroviruses, or ERVs, which are associated with neurological, autoimmune, and oncogenic diseases in humans. Not much is known about these cells, including what exactly triggers their activation and what regulates them. What scientists do know is that not all ERVs are bad– helpful ERVs can help stimulate a retroviral immune response which helps spur tumor cell death. Scientists believe that environmental stimuli, like radiation exposure, likely influences ERV activation; however, more research still needs to be done. Wolves in the CEZ have higher levels of ERV expression, indicating that there are divergent ERV regulatory patterns between wolves that are exposed and unexposed to radiation. While scientists must learn more about ERVs and their effect in wolves, more research is needed on the effects of radiation contamination in the environment and what is driving cancer development in radiation-contaminated habitats (Love et. al, 2020).

Although there is evidence of a genetic component of wolves being resistant to cancer, there is another important factor to keep in mind– human presence. Humans have largely been absent from the CEZ for nearly forty years, so wolves are free from the pressures humans bring. For instance, perhaps for wolves the pressure from hunting is so that it may be better than having to deal with cancer. Essentially, hunting may pose a bigger threat to wolves than cancer. Other human-related pressures these wolves do not face are land, pollution, human disease, and more. However, more research must be done to fully understand all the pressures these wolves are under. While research in the CEZ has been halted because of the war in Ukraine, the wolf population is likely thriving because of a genetic component and from no human pressures (NPR, 2024). 

Researchers hope to return to the region to find and identify these cancer-resilient genes which could inform human cancer treatments. Although their research is paused, the Chernobyl wolf population is a remarkable feat of perseverance and resilience. 

Figure 1. A gray wolf in the Chernobyl Exclusion Zone. (Chernobyl’s Mutant Wolves Have Evolved Anti-Cancer Abilities | IFLScience, n.d.)

Literature Cited

Chernobyl’s Mutant Wolves Have Evolved Anti-Cancer Abilities | IFLScience. (n.d.). Retrieved April 21, 2024, from https://www.iflscience.com/chernobyls-mutant-wolves-have-evolved-anti-cancer-abilities-72831

Hinton, T. G., Byrne, M. E., Webster, S. C., Love, C. N., Broggio, D., Trompier, F., Shamovich, D., Horloogin, S., Lance, S. L., Brown, J., Dowdall, M., & Beasley, J. C. (2019). GPS-coupled contaminant monitors on free-ranging Chernobyl wolves challenge a fundamental assumption in exposure assessments. Environment International, 133, 105152. https://doi.org/10.1016/j.envint.2019.105152

Love et. al (2020). Long-term Implications of Chronic Radiation Exposure: A Genomics Study of Two Canids Reveals Evolutionary and Ecological Impacts of a Nuclear Disaster – ProQuest. (n.d.). Retrieved April 21, 2024, from https://www.proquest.com/openview/f5f17943e75ddda6f147cd66201a344b/1?cbl=18750&diss=y&pq-origsite=gscholar&parentSessionId=Rfd%2FKuzxeAQaOHLv1Bl3gFx7bPxf1AU%2BWGySS9I3SGg%3D

MIT News (1994, January 5). MIT News | Massachusetts Institute of Technology. https://news.mit.edu/1994/safe-0105

NPR: Short Wave. (2024, February 5). NPR. https://www.npr.org/2024/02/05/1198909263/cancer-wolves-ukraine-chernobyl-radiation

Filed Under: Biology, Environmental Science and EOS

The Creation of a Universal Flu Vaccine

December 3, 2023 by Natalie Hayden

Figure 1. Influenza Remains a Threat to the US population (Adapted from CDC, 2022)

 

Influenza, also known as the common flu, infects approximately 8% of the United States population annually, leading to 140,000-710,000 hospitalizations and 12,000-52,000 deaths from 2010 to 2020  (CDC, 2023) (CDC, 2022). Influenza is becoming more prevalent, causing more infections, hospitalizations, and deaths (see Figure 1). Those most at risk include the very young, the elderly, and those with chronic medical conditions (Schmidt & Lapuente, 2021). Common symptoms of influenza include fever, cough, sore throat, runny nose, and fatigue (CDC, 2023). An annual vaccine offers the best protection against influenza, however, this vaccine has drawbacks. A universal vaccine, while still under development, would largely alleviate these issues. For example, a universal vaccine would teach the immune system to protect against all strains of influenza, not just the strain that happens to be circulating during the flu season. 

There are 4 distinct types of influenza genera that circulate: A (IAV), B (IBV), C (ICV), and D (IDV). IAV and IBV are most prevalent in human infections. IBV has a limited host range and strain diversity whereas IAV is constantly creating new lineages and subtypes. IAV alters through genetic drift, the exchange of gene segments among different IAV strands, and because its viral polymerase lacks proofreading activity, causing a backup of mutations. Therefore, IAV poses a greater risk for causing a pandemic. Influenza strains can  be further classified by their glycoproteins: hemagglutinin (HA), which has 3 types– 1 (H1), 2 (H2), and 3 (H3) – and neuraminidase (NA) which has 2 types– 1 (N1) and 2 (N2). These antigens are highly variable among strains and no single vaccine offers full protection against them. The most devastating influenza outbreak in 1918, often dubbed the Spanish Flu, was caused by the H1N1 IAV that led to fifty million deaths worldwide (CDC, 2022). Most recently, in 2009, the H1N1 IAV, known as swine flu, swept the globe at an unprecedented rate due to airline travel. Additional influenza pandemics caused by IAV have appeared more and more frequently as our world becomes increasingly connected. Further, the coronavirus pandemic demonstrated the impact a pandemic may have on nearly every aspect of daily life. IAV remains a constant threat as it has the potential to become a pandemic once more.

Figure 2. History of Influenza A Virus Outbreaks (Adapted from Al Hajjar & McIntosh, 2010)

 

Vaccines are the best protection against influenza, however, current vaccines have many drawbacks. To develop the annual vaccine, scientists must first predict and identify which strain will dominate the flu season. Even if their predictions are correct, the vaccine efficacy (VE) will still be less than 70%. However, if their predictions are incorrect, the VE will be close to 0%. This process is also slow; it takes six months after an influenza outbreak to make a vaccine commercially available to the public. Existing influenza vaccines are imperfect and depend on strain-specific neutralizing antibodies, leaving them vulnerable to new strain mutations.

Figure 3. Varying Types of Influenza Vaccines (Adapted from Al Hajjar & McIntosh, 2010)

 

A universal influenza vaccine would alleviate many of these issues and offer broad immunity. While the annual vaccine’s VE depends largely on how the virus mutates over the duration of the flu season, a universal vaccine would develop protection against conserved parts of the influenza virion. To create a universal vaccine, scientists study the similarities across flu strains to isolate identical segments and then train the immune system to make protective antibodies. As early as 1965, Jerome Schulman and Edwin Kilbourne noticed that mice recovered from a prior H1N1 infection were partially protected against virus replication, mortality, and lung tissue damage after an H2N2 infection. Immune cells called T cells are crucial to this protection. In mice and humans, T cell responses are centered on internal virus proteins such as nucleoproteins, polymerases, and more. Other types of T cells are more diverse and can recognize surface proteins HA and NA. One study found IAV-specific T cell responses at a baseline of 43% in the study population and discovered that the presence of viral nucleoprotein-specific T cells significantly decreased the chance of developing a symptomatic IAV infection. Other studies have confirmed that T cells show a strong inverse correlation to symptom scores. Many of these studies with T cells have done well with animal models but not many have progressed to human clinical trials.

While a universal vaccine is still being developed, it will be extremely beneficial. Recent vaccines are not sufficient to protect the community against seasonal and pandemic influenza flu strains. A universal flu vaccine would solve many of the issues current vaccines present and would offer a higher VE. While they are still a work in progress, these vaccines have great potential and importance.

 

Works Cited

Al Hajjar, S., & McIntosh, K. (2010). The first influenza pandemic of the 21st century. Annals of Saudi Medicine, 30(1), 1–10. https://doi.org/10.4103/0256-4947.59365

CDC. (2022, October 4). Burden of Influenza. Centers for Disease Control and Prevention. https://www.cdc.gov/flu/about/burden/index.html

CDC. (2023, May 2). Key Facts About Influenza (Flu). Centers for Disease Control and Prevention. https://www.cdc.gov/flu/about/keyfacts.htm

Schmidt, A., & Lapuente, D. (2021). T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine. Viruses, 13(2), Article 2. https://doi.org/10.3390/v13020199

Filed Under: Science

Primary Sidebar

CATEGORY CLOUD

Biology Chemistry and Biochemistry Computer Science and Tech Environmental Science and EOS Honors Projects Math and Physics Psychology and Neuroscience Science

RECENT POSTS

  • Biological ChatGPT: Rewriting Life With Evo 2 May 4, 2025
  • Unsupervised Thematic Clustering for Genre Classification in Literary Texts May 4, 2025
  • Motor Brain-Computer Interface Reanimates Paralyzed Hand May 4, 2025

FOLLOW US

  • Facebook
  • Twitter

Footer

TAGS

AI AI ethics Alzheimer's Disease antibiotics artificial intelligence bacteria Bathymetry Beavers Biology brain Cancer Biology Cell Biology Chemistry and Biochemistry Chlorofluorocarbons climate change Computer Science and Tech CRISPR Cytoskeleton Depression dreams epigenetics Ethics Genes honors Luis Vidali Marine Biology Marine Mammals Marine noise Medicine memory Montreal Protocol Moss neurobiology neuroscience Nutrients Ozone hole Plants Psychology and Neuroscience REM seabirds sleep student superintelligence Technology therapy

Copyright © 2025 · students.bowdoin.edu